###begin article-title 0
Novel Meta-Analysis-Derived Type 2 Diabetes Risk Loci Do Not Determine Prediabetic Phenotypes
###end article-title 0
###begin p 1
Conceived and designed the experiments: NS AF HUH. Performed the experiments: FM KK SAS KK MG GS. Analyzed the data: HS FM NS AF. Contributed reagents/materials/analysis tools: FM HUH. Wrote the paper: HS.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Genome-wide association (GWA) studies identified a series of novel type 2 diabetes risk loci. Most of them were subsequently demonstrated to affect insulin secretion of pancreatic beta-cells. Very recently, a meta-analysis of GWA data revealed nine additional risk loci with still undefined roles in the pathogenesis of type 2 diabetes. Using our thoroughly phenotyped cohort of subjects at an increased risk for type 2 diabetes, we assessed the association of the nine latest genetic variants with the predominant prediabetes traits, i.e., obesity, impaired insulin secretion, and insulin resistance.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAZF1</italic>
###xml 198 211 198 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDC123/CAMK1D</italic>
###xml 224 235 224 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8/LGR5</italic>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 264 271 264 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 283 289 283 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 302 305 302 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCD</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 338 344 338 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL11A</italic>
###xml 869 876 863 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 895 900 889 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
One thousand five hundred and seventy-eight metabolically characterized non-diabetic German subjects were genotyped for the reported candidate single nucleotide polymorphisms (SNPs) JAZF1 rs864745, CDC123/CAMK1D rs12779790, TSPAN8/LGR5 rs7961581, THADA rs7578597, ADAMTS9 rs4607103, NOTCH2 rs10923931, DCD rs1153188, VEGFA rs9472138, and BCL11A rs10490072. Insulin sensitivity was derived from fasting glucose and insulin concentrations, oral glucose tolerance test (OGTT), and hyperinsulinemic-euglycemic clamp. Insulin secretion was estimated from OGTT data. After appropriate adjustment for confounding variables and Bonferroni correction for multiple comparisons (corrected alpha-level: p = 0.0014), none of the SNPs was reliably associated with adiposity, insulin sensitivity, or insulin secretion (all p>/=0.0117, dominant inheritance model). The risk alleles of ADAMTS9 SNP rs4607103 and VEGFA SNP rs9472138 tended to associate with more than one measure of insulin sensitivity and insulin secretion, respectively, but did not reach formal statistical significance. The study was sufficiently powered (1-beta = 0.8) to detect effect sizes of 0.19</=d</=0.25 (alpha = 0.0014) and 0.13</=d</=0.16 (alpha = 0.05).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 198 205 198 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
In contrast to the first series of GWA-derived type 2 diabetes candidate SNPs, we could not detect reliable associations of the novel risk loci with prediabetic phenotypes. Possible weak effects of ADAMTS9 SNP rs4607103 and VEGFA SNP rs9472138 on insulin sensitivity and insulin secretion, respectively, await further confirmation by larger studies.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 339 342 339 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Freeman1">[1]</xref>
###xml 692 695 689 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Weyer1">[2]</xref>
Type 2 diabetes mellitus results from an interaction between environmental factors, such as high-caloric nutrition and reduced physical activity, and a predisposing polygenic background. More explicitly, common variation within several genes is thought to confer enhanced susceptibility towards the aforementioned environmental challenges [1]. During the pathogenesis of type 2 diabetes, peripheral tissues, such as liver, skeletal muscle, and adipose tissue, develop insulin resistance which provokes compensatory increments in pancreatic insulin secretion. When insulin resistance reaches extents no longer compensated by the beta-cell, insulin secretion declines and hyperglycemia emerges [2]. Thus, genetic variation in type 2 diabetes risk genes is supposed to affect insulin sensitivity and/or beta-cell function.
###end p 9
###begin p 10
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 191 197 191 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 203 209 203 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 305 312 305 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 320 326 320 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 328 335 328 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF2BP2</italic>
###xml 341 349 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/B</italic>
###xml 349 352 349 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Sladek1">[3]</xref>
###xml 353 356 353 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Scott1">[6]</xref>
###xml 482 485 482 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Omori1">[7]</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Duesing1">[14]</xref>
Last year, genome-wide association (GWA) studies based on several thousands of cases and controls not only confirmed the importance of earlier type 2 diabetes candidate genes, such as PPARG, KCNJ11, and TCF7L2, but also identified single nucleotide polymorphisms (SNPs) within five novel risk loci, i.e., SLC30A8, HHEX, CDKAL1, IGF2BP2, and CDKN2A/B[3]-[6]. The association of the novel loci with type 2 diabetes was subsequently reproduced in several other cohorts and ethnicities [7]-[14]. Furthermore, analysis of cohorts phenotyped with state-of-the-art methods for measurement of insulin sensitivity and insulin secretion recently revealed that the novel genetic variants affect insulin secretion, but not insulin sensitivity [10;15-21].
###end p 10
###begin p 11
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Zeggini2">[22]</xref>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAZF1</italic>
###xml 297 310 297 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDC123/CAMK1D</italic>
###xml 312 323 312 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8/LGR5</italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 332 339 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 341 347 341 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 349 352 349 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCD</italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 365 371 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL11A</italic>
In a very recent meta-analysis of GWA data, nine additional risk loci were identified with equal or weaker association with type 2 diabetes (odds ratios: 1.05-1.15) as compared to the first series of novel risk loci (odds ratios: 1.12-1.37) [22]. The role of the corresponding genes, i.e., JAZF1, CDC123/CAMK1D, TSPAN8/LGR5, THADA, ADAMTS9, NOTCH2, DCD, VEGFA, and BCL11A, in the pathogenesis of prediabetes phenotypes was not yet assessed and is not established in the literature. Therefore, it was the aim of the present study to test the association of the nine most recent candidate SNPs with obesity, insulin resistance, and beta-cell dysfunction in a thoroughly metabolically characterized population at an increased risk for type 2 diabetes from Southern Germany.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Subjects
###end title 13
###begin p 14
###xml 1027 1029 1015 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</sup>
###xml 431 443 <span type="species:ncbi:9606">participants</span>
###xml 1072 1084 <span type="species:ncbi:9606">participants</span>
###xml 1405 1417 <span type="species:ncbi:9606">participants</span>
###xml 1565 1577 <span type="species:ncbi:9606">participants</span>
One thousand seven hundred and twenty subjects were recruited from the ongoing Tubingen Family Study for type 2 diabetes (TUF) which currently includes approximately2000 individuals. The publicly announced call for TUF primarily addressed non-diabetic individuals from Southern Germany at an increased risk for type 2 diabetes (family history of type 2 diabetes, diagnosis of impaired fasting glycemia). More than 99.5% of the TUF participants are of European ancestry. Selection of the study cohort was based on availability of DNA samples and C-peptide measurements. From the 1720 subjects, 45 were excluded due to incomplete data sets and 97 due to newly diagnosed type 2 diabetes. These exclusions resulted in a non-diabetic cohort of 1578 subjects (1139 with normal glucose tolerance, 164 with impaired fasting glycemia, 152 with impaired glucose tolerance, and 123 with impaired fasting glycemia and impaired glucose tolerance). 68% of these subjects had a recorded family history of type 2 diabetes, i.e., at least one 2nd-degree relative with type 2 diabetes. All participants underwent the standard procedures of the protocol including medical history and physical examination, assessment of smoking status, alcohol consumption habits and activity, routine blood tests, and oral glucose tolerance test (OGTT). A subgroup of 513 subjects agreed to undergo a hyperinsulinemic-euglycemic clamp. The participants were not taking any medication known to affect glucose tolerance or insulin secretion. Informed written consent to the study was obtained from the participants, and the local ethics committee (Ethik-Kommission der Medizinischen Fakultat der Universitat Tubingen) approved the study protocol.
###end p 14
###begin title 15
Genotyping of the study population
###end title 15
###begin p 16
For genotyping, DNA was isolated from whole blood using a commercial DNA isolation kit (NucleoSpin, Macherey & Nagel, Duren, Germany). SNPs were genotyped using the TaqMan assay (Applied Biosystems, Foster City, CA, USA). The TaqMan genotyping reaction was amplified on a GeneAmp PCR system 7000 (50degreesC for 2 min, 95degreesC for 10 min, followed by 40 cycles of 95degreesC for 15s and 60degreesC for 1 min), and fluorescence was detected on an ABI Prism sequence detector (Applied Biosystems, Foster City, CA, USA). The assay was validated by bidirectional sequencing in 50 subjects, and both methods gave 100% identical results. The overall genotyping success rate was 99.5% (rs864745: 99.7%, rs12779790: 97.8%, rs7961581: 99.4%, rs7578597: 99.9%, rs4607103: 99.2%, rs10923931: 100%, rs1153188: 99.7%, rs9472138: 99.7%, rs10490072: 99.9%), and rescreening of 3.2% of subjects resulted in 100% identical results.
###end p 16
###begin title 17
Determination of adiposity
###end title 17
###begin p 18
Percentage of body fat was measured by bioelectrical impedance (BIA-101, RJL systems, Detroit, MI, USA). Body mass index (BMI) was calculated as weight divided by squared height. Waist circumference was measured in the upright position at the midpoint between the lateral iliac crest and the lowest rib.
###end p 18
###begin title 19
OGTT
###end title 19
###begin p 20
After a 10h overnight fast, all subjects underwent a 75g OGTT and venous blood samples were obtained at 0, 30, 60, 90, and 120min for determination of plasma glucose, insulin, and C-peptide.
###end p 20
###begin title 21
Hyperinsulinemic-euglycemic clamp
###end title 21
###begin p 22
###xml 132 133 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 151 156 <span type="species:ncbi:9606">human</span>
After an overnight fast and a 60min baseline period, 513 subjects received a priming dose of insulin followed by an infusion (40mU/m2) of short-acting human insulin for 120 min. A variable infusion of 20% glucose was started to maintain the fasting plasma glucose concentration. Blood samples for the measurement of plasma glucose were obtained at 5 min intervals throughout the clamp. Plasma insulin levels were measured at baseline and in the steady state of the clamp.
###end p 22
###begin title 23
Determination of blood parameters
###end title 23
###begin p 24
Plasma glucose was determined using a bedside glucose analyzer (glucose oxidase method, Yellow Springs Instruments, Yellow Springs, CO, USA). Plasma insulin and C-peptide concentrations were measured by commercial chemiluminescence assays for ADVIA Centaur (Siemens Medical Solutions, Fernwald, Germany) according to the manufacturer's instructions. The inter-assay coefficients of variation were <5% (insulin assay) and <6% (C-peptide assay).
###end p 24
###begin title 25
Calculations
###end title 25
###begin p 26
###xml 144 145 144 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 156 158 156 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sub>
###xml 169 171 169 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">60</sub>
###xml 182 184 182 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 199 202 199 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">120</sub>
###xml 577 581 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Stumvoll1">[23]</xref>
###xml 605 607 605 607 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sub>
###xml 624 626 624 626 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sub>
###xml 643 644 643 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 736 737 736 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 748 749 748 749 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Matsuda1">[24]</xref>
###xml 861 862 861 862 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 873 874 873 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 885 889 885 889 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mean</sub>
###xml 900 904 900 904 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mean</sub>
###xml 905 910 905 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#189;</sup>
The area under the curve (AUC) of plasma glucose levels during the OGTT was calculated according to the trapezoid method as: 0.5.[0.5.c(glucose)0+c(glucose)30+c(glucose)60+c(glucose)90+0.5.c(glucose)120]. The AUC of plasma C-peptide levels during the OGTT was calculated analogously. Insulin secretion in the OGTT was assessed by calculating the ratio of the AUC of C-peptide divided through the AUC of glucose (AUC C-pep/AUC glc). First-phase insulin secretion was estimated from plasma insulin and glucose concentrations during the OGTT using the formerly described equation [23]: 1,283+1.829.c(insulin)30-138.7.c(glucose)30+3.772.c(insulin)0. Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as [c(glucose)0.c(insulin)0]/22.5. Insulin sensitivity from OGTT was estimated as proposed by Matsuda and DeFronzo [24]: 10,000/[c(glucose)0.c(insulin)0.c(glucose)mean.c(insulin)mean](1/2). Clamp-derived insulin sensitivity was calculated as glucose infusion rate necessary to maintain euglycemia during the last 40min (steady state) of the clamp divided by the steady-state insulin concentration.
###end p 26
###begin title 27
Statistical analyses
###end title 27
###begin p 28
###xml 47 48 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Hardy-Weinberg equilibrium was tested using chi2 test. Prior to statistical analysis, all continuous data were log-transformed in order to approximate normal distribution. To adjust for confounding variables, multivariate linear regression models were applied, and the trait of interest (e.g., BMI, insulin sensitivity index, or insulin secretion index) was chosen as dependent variable. Multivariate linear regression analysis was performed using the least-squares method. Based on testing nine non-linked SNPs and four independent parameters (i.e., age, measures of adiposity, measures of insulin secretion, and measures of insulin action), we performed 36 independent statistical tests. Therefore, a p-value<0.0014 was considered statistically significant according to Bonferroni correction for multiple comparisons. For these analyses, the statistical software package JMP 4.0 (SAS Institute, Cary, NC, USA) was used. In the dominant inheritance model using one-tailed t-test, our study was sufficiently powered (1-beta = 0.8, alpha = 0.0014) to detect effect sizes (d) of 0.19</=d</=0.25 depending on the minor allele frequency (MAF) of the SNP tested. At the nominal alpha-level of 0.05, the study was sufficiently powered to detect effect sizes of 0.13</=d</=0.16. In the subgroup of clamped subjects, the study was sufficiently powered to detect effect sizes of 0.34</=d</=0.46 (1-beta = 0.8, alpha = 0.0014) or of 0.22</=d</=0.30 (1-beta = 0.8, alpha = 0.05). Power calculations were performed using G*power 3.0 software available at .
###end p 28
###begin title 29
Results
###end title 29
###begin p 30
###xml 75 82 75 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003019-t001">Table 1</xref>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAZF1</italic>
###xml 245 251 245 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDC123</italic>
###xml 256 262 256 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAMK1D</italic>
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8</italic>
###xml 321 325 321 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LGR5</italic>
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 466 473 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 524 530 524 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 611 617 611 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAM30</italic>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Zeggini2">[22]</xref>
###xml 673 676 673 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCD</italic>
###xml 736 741 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 805 811 805 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL11A</italic>
###xml 937 941 937 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Zeggini2">[22]</xref>
###xml 943 951 943 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003019-t002">Tables 2</xref>
###xml 953 954 953 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003019-t003">3</xref>
###xml 956 957 956 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003019-t004">4</xref>
We genotyped 1578 non-diabetic subjects (clinical characteristics given in Table 1) for the following type 2 diabetes candidate SNPs: the intronic SNP rs864745 in the JAZF1 gene (chr. 7), SNP rs12779790 located in the genomic region between the CDC123 and CAMK1D genes (chr. 10), SNP rs7961581 located between TSPAN8 and LGR5 (chr. 12), SNP rs7578597 in exon 24 of the THADA gene (chr. 2) resulting in the missense mutation T1187A, the intronic SNP rs4607103 in the ADAMTS9 gene (chr. 3), the intronic SNP rs10923931 in the NOTCH2 gene (chr. 1; in near-complete linkage disequilibrium with SNP rs2641348 in the ADAM30 gene [22]), SNP rs1153188 nearest (5'-flanking) to the DCD gene (chr. 12), SNP rs9472138 nearest (3'-flanking) to the VEGFA gene (chr. 6), and SNP rs10490072 nearest (3'-flanking) to the BCL11A gene (chr. 2). All SNPs were in Hardy-Weinberg equilibrium (all p>0.1) and displayed MAFs similar to those recently reported [22] (Tables 2, 3, 4).
###end p 30
###begin title 31
Clinical characteristics of the study population (N = 1578: 1139 NGT, 164 IFG, 152 IGT, 123 IFG+IGT).
###end title 31
###begin p 32
IFG-impaired fasting glycemia; IGT-impaired glucose tolerance; NGT-normal glucose tolerance.
###end p 32
###begin title 33
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAZF1</italic>
###xml 36 49 36 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDC123/CAMK1D</italic>
###xml 70 81 70 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8/LGR5</italic>
Associations of JAZF1 SNP rs864745, CDC123/CAMK1D SNP rs12779790, and TSPAN8/LGR5 SNP rs7961581 with anthropometrics, insulin sensitivity, and insulin secretion (N = 1578).
###end title 33
###begin p 34
###xml 361 362 359 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 389 390 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Data represent means+/-SD. For statistical analysis, data were log-transformed. Age was adjusted for gender. BMI, body fat, and waist circumference were adjusted for gender and age. Plasma glucose levels and indices of insulin sensitivity were adjusted for gender, age, and BMI. Indices of insulin secretion were adjusted for gender, age, BMI, and ISI (OGTT). p1-p-value, additive model; p2-p-value, dominant model. AUC-area under the curve; HOMA-IR-homeostasis model assessment of insulin resistance; ISI-insulin sensitivity index; MAF-minor allele frequency; SNP-single nucleotide polymorphism.
###end p 34
###begin p 35
subgroup (N = 513).
###end p 35
###begin title 36
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt106">#</xref>
Associations of THADA SNP rs7578597, ADAMTS9 SNP rs4607103, and NOTCH2 SNP rs10923931# with anthropometrics, insulin sensitivity, and insulin secretion (N = 1578).
###end title 36
###begin p 37
###xml 361 362 359 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 389 390 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Data represent means+/-SD. For statistical analysis, data were log-transformed. Age was adjusted for gender. BMI, body fat, and waist circumference were adjusted for gender and age. Plasma glucose levels and indices of insulin sensitivity were adjusted for gender, age, and BMI. Indices of insulin secretion were adjusted for gender, age, BMI, and ISI (OGTT). p1-p-value, additive model; p2-p-value, dominant model. AUC-area under the curve; HOMA-IR-homeostasis model assessment of insulin resistance; ISI-insulin sensitivity index; MAF-minor allele frequency; SNP-single nucleotide polymorphism.
###end p 37
###begin p 38
subgroup (N = 513).
###end p 38
###begin p 39
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAM30</italic>
in linkage with ADAM30 SNP rs2641348.
###end p 39
###begin title 40
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DCD</italic>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCL11A</italic>
Associations of DCD SNP rs1153188, VEGFA SNP rs9472138, and BCL11A SNP rs10490072 with anthropometrics, insulin sensitivity, and insulin secretion (N = 1578).
###end title 40
###begin p 41
###xml 361 362 359 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 389 390 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Data represent means+/-SD. For statistical analysis, data were log-transformed. Age was adjusted for gender. BMI, body fat, and waist circumference were adjusted for gender and age. Plasma glucose levels and indices of insulin sensitivity were adjusted for gender, age, and BMI. Indices of insulin secretion were adjusted for gender, age, BMI, and ISI (OGTT). p1-p-value, additive model; p2-p-value, dominant model. AUC-area under the curve; HOMA-IR-homeostasis model assessment of insulin resistance; ISI-insulin sensitivity index; MAF-minor allele frequency; SNP-single nucleotide polymorphism.
###end p 41
###begin p 42
subgroup (N = 513).
###end p 42
###begin p 43
###xml 389 397 381 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003019-t002">Tables 2</xref>
###xml 399 400 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003019-t003">3</xref>
###xml 402 403 394 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003019-t004">4</xref>
###xml 700 709 692 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003019.s001">Tables S1</xref>
###xml 711 713 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003019.s002">S2</xref>
###xml 715 717 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003019.s003">S3</xref>
###xml 719 721 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003019.s004">S4</xref>
###xml 723 725 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003019.s005">S5</xref>
###xml 727 729 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003019.s006">S6</xref>
###xml 445 450 <span type="species:ncbi:9606">women</span>
###xml 454 457 <span type="species:ncbi:9606">men</span>
###xml 558 563 <span type="species:ncbi:9606">women</span>
###xml 568 571 <span type="species:ncbi:9606">men</span>
After appropriate adjustment for confounding variables and Bonferroni correction for multiple comparisons (corrected alpha-level: p = 0.0014), none of the SNPs was reliably associated with age, adiposity, plasma glucose concentrations, insulin sensitivity, or insulin secretion either in the additive (all p>/=0.0042) or in the dominant inheritance model (all p>/=0.0017), as presented in Tables 2, 3, 4. Since our cohort included twice as many women as men and adjusting for gender might not completely account for this difference, we performed analyses in women and men separately. However, these analyses did not provide more reliable associations than the analysis of the total study population (Tables S1, S2, S3, S4, S5, S6).
###end p 43
###begin p 44
###xml 248 259 244 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8/LGR5</italic>
###xml 349 354 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 426 433 422 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 507 512 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 682 689 678 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 731 736 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 826 830 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Zeggini2">[22]</xref>
By analysing each SNP for trends of association (arbitrary alpha-level: p = 0.07, dominant inheritance model) with more than one measure of adiposity, insulin sensitivity, or insulin secretion, respectively, the following trends were observed: the TSPAN8/LGR5 SNP rs7961581 tended to associate with OGTT-derived insulin sensitivity and HOMA-IR, the THADA SNP rs7578597 with BMI, body fat content, and waist circumference, the ADAMTS9 SNP rs4607103 with OGTT-derived insulin sensitivity and HOMA-IR, and the VEGFA SNP rs9472138 with C-peptide levels at 30 min of OGTT and AUC C-pep/AUC glc. After determination of the risk alleles for these associations, only the risk allele of the ADAMTS9 SNP rs4607103 and the risk allele of the VEGFA SNP rs9472138 were identical with the recently reported risk alleles for type 2 diabetes [22].
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 284 288 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Staiger1">[15]</xref>
###xml 290 294 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Kirchhoff1">[16]</xref>
###xml 427 431 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Zeggini2">[22]</xref>
###xml 591 595 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Zeggini2">[22]</xref>
In our thoroughly phenotyped cohort, we could recently demonstrate that several of the type 2 diabetes candidate SNPs identified in the course of the first round of GWA analysis were significantly associated with beta-cell dysfunction and/or impaired proinsulin-to-insulin conversion [15], [16]. In the present study, we assessed the association of the nine latest candidate SNPs identified by recent meta-analysis of GWA data [22] with prediabetic traits. As compared to the first series, these latest SNPs displayed only very weak association with type 2 diabetes (odds ratios: 1.05-1.15) [22] and, thus, might also include false-positives. Taking this suggestion and the large number of statistical tests performed into account, we rigorously applied Bonferroni correction for multiple comparisons in order to minimize the number of statistical type 1 errors. By analysing the data in this way, we could not detect any reliable association of the candidate SNPs with the prediabetes traits obesity, insulin resistance, or impaired insulin secretion.
###end p 46
###begin p 47
###xml 135 142 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 165 170 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
###xml 348 355 344 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 360 365 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
By analysing each SNP for trends of association (arbitrary alpha-level: p = 0.07, dominant inheritance model), the risk alleles of the ADAMTS9 SNP rs4607103 and the VEGFA SNP rs9472138 tended to associate with more than one measure of insulin sensitivity and insulin secretion, respectively. Thus, one could speculate that genetic variation within ADAMTS9 and VEGFA may exert weak effects on these traits. To corroborate these findings, further studies in larger and comparably well-phenotyped cohorts are needed which allow the reliable detection of effect sizes smaller than d = 0.19. However, the clinical relevance of such small effects remains to be determined.
###end p 47
###begin p 48
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAZF1</italic>
###xml 104 117 104 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDC123/CAMK1D</italic>
###xml 119 130 119 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8/LGR5</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 139 146 139 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 152 158 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Grarup2">[25]</xref>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THADA</italic>
###xml 397 404 397 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 410 416 410 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOTCH2</italic>
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAZF1</italic>
###xml 603 616 603 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDC123/CAMK1D</italic>
###xml 622 633 622 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8/LGR5</italic>
###xml 687 700 687 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDC123/CAMK1D</italic>
###xml 1200 1205 1200 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">JAZF1</italic>
###xml 1207 1220 1207 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDC123/CAMK1D</italic>
###xml 1225 1236 1225 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSPAN8/LGR5</italic>
###xml 1646 1650 1643 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003019-Grarup2">[25]</xref>
A very recently published study investigated associations of the type 2 diabetes risk alleles in JAZF1, CDC123/CAMK1D, TSPAN8/LGR5, THADA, ADAMTS9, and NOTCH2 with obesity, insulin sensitivity, and insulin secretion in 4516 Danes [25]. This study confirms our negative findings for a role of these SNPs in adiposity and insulin sensitivity as well as our negative results for a role of the THADA, ADAMTS9, and NOTCH2 SNPs in insulin secretion. However, using OGTT-based estimates of insulin secretion derived from plasma insulin and glucose levels, these authors demonstrated associations of the JAZF1, CDC123/CAMK1D, and TSPAN8/LGR5 SNPs with insulin secretion. Only the association of CDC123/CAMK1D SNP rs12779790 with the insulinogenic index resisted Bonferroni correction for multiple comparisons. Even though we feel that C-peptide measurements, as performed in our study, are more reliable in estimating insulin release than insulin data, which are biased by insulin resistance and insulin clearance, our study is of limited statistical power and our negative findings (which could reflect statistical type 2 errors) are therefore insufficient to reject a possible role of genetic variation in JAZF1, CDC123/CAMK1D, or TSPAN8/LGR5 in beta-cell dysfunction. Thus, larger studies with C-peptide measurements or studies using more sophisticated methods for the measurement of insulin secretion, such as the intravenous glucose tolerance test or the hyperglycemic clamp, are needed to ultimately address this issue. Alternative measures of insulin secretion in addition to the OGTT-derived measures reported in the present and the former study [25] are particularly important in order to capture all of the various aspects of insulin secretion capacity.
###end p 48
###begin p 49
###xml 418 425 418 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS9</italic>
###xml 444 449 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFA</italic>
In conclusion, none of the tested candidate SNPs displayed significant association with crucial prediabetes phenotypes. Since it is highly plausible that type 2 diabetes candidate SNPs affect adiposity, insulin sensitivity, or insulin secretion, our negative findings could point to the possibility that these SNPs' associations with type 2 diabetes in part reflect statistical type 1 errors. Possible weak effects of ADAMTS9 SNP rs4607103 and VEGFA SNP rs9472138 on insulin sensitivity and insulin secretion, respectively, cannot be excluded and await further confirmation by larger studies.
###end p 49
###begin title 50
Supporting Information
###end title 50
###begin p 51
Supplementary Table 1
###end p 51
###begin p 52
(0.06 MB DOC)
###end p 52
###begin p 53
Click here for additional data file.
###end p 53
###begin p 54
Supplementary Table 2
###end p 54
###begin p 55
(0.06 MB DOC)
###end p 55
###begin p 56
Click here for additional data file.
###end p 56
###begin p 57
Supplementary Table 3
###end p 57
###begin p 58
(0.06 MB DOC)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin p 60
Supplementary Table 4
###end p 60
###begin p 61
(0.06 MB DOC)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
Supplementary Table 5
###end p 63
###begin p 64
(0.06 MB DOC)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
Supplementary Table 6
###end p 66
###begin p 67
(0.06 MB DOC)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
###xml 19 31 <span type="species:ncbi:9606">participants</span>
We thank all study participants for their cooperation. We thank the International HapMap Consortium for the public allocation of genotype data. We gratefully acknowledge the excellent technical assistance of Anna Bury, Heike Luz, Alke Guirguis, Melanie Weisser, and Roman Werner.
###end p 69
###begin title 70
References
###end title 70
###begin article-title 71
Type-2 diabetes: a cocktail of genetic discovery.
###end article-title 71
###begin article-title 72
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
###end article-title 72
###begin article-title 73
A genome-wide association study identifies novel risk loci for type 2 diabetes.
###end article-title 73
###begin article-title 74
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
###end article-title 74
###begin article-title 75
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
###end article-title 75
###begin article-title 76
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
###end article-title 76
###begin article-title 77
Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population.
###end article-title 77
###begin article-title 78
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 129 141 <span type="species:ncbi:9606">participants</span>
Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study).
###end article-title 78
###begin article-title 79
Variation in the HHEX-IDE gene region predisposes to type 2 diabetes in the prospective, population-based EPIC-Potsdam cohort.
###end article-title 79
###begin article-title 80
Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.
###end article-title 80
###begin article-title 81
Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population.
###end article-title 81
###begin article-title 82
Polymorphisms in the IDE-KIF11-HHEX gene locus are reproducibly associated with type 2 diabetes in a Japanese population.
###end article-title 82
###begin article-title 83
HHEX gene polymorphisms are associated with type 2 diabetes in the Dutch Breda cohort.
###end article-title 83
###begin article-title 84
Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids.
###end article-title 84
###begin article-title 85
Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
###end article-title 85
###begin article-title 86
Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion.
###end article-title 86
###begin article-title 87
###xml 141 149 <span type="species:ncbi:9606">patients</span>
The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients-the EUGENE2 study.
###end article-title 87
###begin article-title 88
Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function.
###end article-title 88
###begin article-title 89
A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study.
###end article-title 89
###begin article-title 90
Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study.
###end article-title 90
###begin article-title 91
###xml 169 172 <span type="species:ncbi:9606">men</span>
SNP rs7754840 of CDKAL1 is associated with impaired insulin secretion in non-diabetic offspring of Type 2 diabetic subjects (the EUGENE2 study) and in a large sample of men with normal glucose tolerance.
###end article-title 91
###begin article-title 92
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
###end article-title 92
###begin article-title 93
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.
###end article-title 93
###begin article-title 94
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.
###end article-title 94
###begin article-title 95
Association testing of novel type 2 diabetes risk-alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes.
###end article-title 95
###begin p 96
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 96
###begin p 97
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The study was supported by a grant from the German Research Foundation (KFO 114/2). The funding organisation is a non-profit organisation and was not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.
###end p 97

